Archive: startups

Premium
Investing during a pandemic requires new rules. And this startup checks off all the boxes.

Big Oil’s Problems Are Just Beginning

By Andy Gordon on April 15, 2020

The world’s oil-producing countries reached an agreement to cut production earlier this year. But the deal is too little, too late. And it’s just the beginning of the problems facing the oil industry.
Premium
As the COVID-19 pandemic continues, early-stage deals look pretty much the same so far. What’s up with that?
Premium

World Tree Adjusting to COVID-19 Disruptions

By Andy Gordon on April 13, 2020

World Tree explains how it's adjusting to the economic disruption caused by the COVID-19 pandemic.

Webinar: New Crowdfunding Portal Comes Online

By Andy Gordon on April 13, 2020

Crowdfunding portals are a critical part of the startup investing ecosystem. And the newest investment platform in the group, Equifund, is trying to add some new wrinkles in the space. Meet Equifund's founder and CEO, Jordan Gillissie, in this special webinar.

Is the Worst Over?

By Adam Sharp on April 10, 2020

Stocks are soaring. Is the worst of this crisis over, or are we in the eye of the storm?
Premium

Investing in Video Games

By Adam Sharp on April 9, 2020

Adam Sharp invites a video game insider to help us understand the outlook for one of the few red-hot sectors in the middle of a pandemic-induced economic slowdown.

Public vs. Private Shares? It’s No Contest

By Andy Gordon on April 8, 2020

Investors take on a little more risk by buying into startups in a tough business environment. But the outsized rewards justify the investment.
Premium

A Great Time for Startup Investing

By Adam Sharp on April 7, 2020

The COVID-19 pandemic is revealing flaws in our economy - and creating a great opportunity for startup investors.
Premium

Demand for Startup WhereBy.Us Is Surging

By Andy Gordon on April 6, 2020

The COVID-19 pandemic has made getting reliable news and information more valuable than ever. And startup WhereBy.Us has seen an increase in business as a result.
Premium
A promising Medtech startup is poised to change a key part of the plastic surgery business.
20/20 GeneSystems’ founder and CEO answers questions about the company moving into providing rapid COVID-19 tests.
Premium

Silver Linings

By Adam Sharp on March 31, 2020

There’s not much to like about this situation, but there are a few silver linings. Namely, the fact that we’re likely to see some very impressive deal flow over the next year...
Premium
20/20 GeneSystems founder and CEO answers questions about the company moving into providing rapid COVID-19 tests.
In this special Q&A, Republic answers our questions about the SEC’s proposed changes to crowdfunding and gives us a master class on SAFEs.
Premium

Never a Better Time to Be an Angel

By Adam Sharp on March 24, 2020

The novel coronavirus is shutting down the global economy - and creating good opportunities for angel investors.